Why the Patient Voice is Central to the Benefits of the FDA Guidelines for Pharma

Today's guest post comes from Ido Hadari. Hadari is the CEO of Treato, the health analytics big data platform providing ‘patient voice’ insights to patients and industry stakeholders alike from across the social Web. Ido previously led various technology businesses with a focus on innovation and disruption. His focus at Treato is on similarly disrupting the health industry by bringing the next generation of patient intelligence to pharma. Author Ido Hadari The FDA guidelines for social media best practices in the pharmaceutical industry are, simply put, all about the importance of understanding the patient voice. As the industry focuses on understanding the guidelines and how to execute against them, we find that the larger – albeit more subtle – point is that the FDA clearly recognizes the value of patient conversations on the Internet. The key for Pharma is how to leverage this new force in healthcare: the online empowered patient. At Treato, we see the benefits that the Internet brings to patients every day. The more data we garner on patient experiences, the more informed the pharmaceutical industry becomes, in decision-making around medications and treatments. These are just some of the ways we think patients stand to benefit from the new, more clearly defined guidelines for pharmaceutical companies on social media:1) New Ways to Make an (Unmediated) Difference. As the FDA guidelines suggest, it’s impossible to embrace social media without recognizing tha...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: ePharma ePharma Summit FDA social media guidelines health data analytics Patient voice User generated content Source Type: blogs